| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |